Oberland Capital

Oberland Capital operates as a private investment firm, delivering structured financing solutions exclusively to the global healthcare industry. The firm provides a diverse suite of flexible investment structures, including the monetization of royalty streams, acquisition of future product revenues, and project-based financing, alongside traditional debt and equity investments. This approach is designed to support and accelerate the development and commercialization of promising healthcare products.

The company was founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. Their foundational insight recognized a specific need within the healthcare sector for highly customized and flexible capital, beyond conventional financing options. This perspective allowed them to build a firm uniquely equipped to address the financial complexities inherent in life sciences product development and market entry, leveraging their extensive backgrounds in healthcare and finance.

Oberland Capital partners with management teams across the global healthcare landscape, aiming to align its capital solutions with their strategic and financial objectives. The firm’s long-term vision is centered on creating value for these partners and ultimately enhancing patient care by applying its deep scientific, operational, and financial domain expertise to foster innovation and bring critical healthcare solutions to market.